Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of CDH3 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ce,IHC-P,WB-Tr |
More info about CDH3 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB3539 |
| Product name: | CDH3 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of CDH3. |
| Gene id: | 1001 |
| Gene name: | CDH3 |
| Gene alias: | CDHP|HJMD|PCAD |
| Gene description: | cadherin 3, type 1, P-cadherin (placental) |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human CDH3. |
| Protein accession: | NP_001784;P22223 |
| Form: | Liquid |
| Recommend dilutions: | Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (1:10-50) Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of CDH3 (arrow) using rabbit CDH3 polyclonal antibody (Cat # PAB3539) in K-562 cell line lysates (35 ug/lane). CDH3 (arrow) was detected using the purified polyclonal antibody (1:1000 dilution). |
| Applications: | WB-Ce,IHC-P,WB-Tr |
| Shipping condition: | Dry Ice |
| Publications: | P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.Paredes J, Albergaria A, Oliveira JT, Jeronimo C, Milanezi F, Schmitt FC. Clin Cancer Res. 2005 Aug 15;11(16):5869-77. |